Eudaimonia Asset Management »

Halozyme Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2012-03-31 $626k 49k 12.75

More positions owned by Eudaimonia Asset Management

FTAI Aviation Common Stock (FTAI)
Vaxcyte Common Stock (PCVX)
Sprouts Farmers Market Common Stock (SFM)
Insmed Common Stock (INSM)
CommVault Systems Common Stock (CVLT)
Zeta Global Holdings Corp Common Stock (ZETA)
Cava Group Common Stock (CAVA)
Ensign Group Inc/The Common Stock (ENSG)
Modine Manufacturing Common Stock (MOD)
ACI Worldwide Common Stock (ACIW)
Lantheus Holdings Common Stock (LNTH)
Piper Sandler Cos Common Stock (PIPR)
Glaukos Corp Common Stock (GKOS)
UFP Technologies Common Stock (UFPT)
StepStone Group Common Stock (STEP)

View all positions for Eudaimonia Asset Management

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics